COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Tocilizumab in COVID-19: Beware the risk of intestinal perforation.
Tocilizumab in COVID-19: Beware the risk of intestinal perforation. Int J Antimicrob Agents. 2020 Jul; 56(1):106009.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Betacoronavirus
Coronavirus Infections
Humans
Intestinal Perforation
Pandemics
Peptidyl-Dipeptidase A
Pneumonia, Viral
authors with profiles
Brandon Michael Henry
Jens Vikse